Brief: Standard Biotools Announces Preliminary Fourth Quarter And Full Year 2024 Revenue
13/01/2025 13:42
Jan 13 (Reuters) - Standard BioTools Inc LAB.O :
* STANDARD BIOTOOLS ANNOUNCES PRELIMINARY FOURTH QUARTER AND
FULL
YEAR 2024 REVENUE
* EXPECTS Q4 2024 REVENUE OF APPROXIMATELY $46.5 MILLION
* EXPECTS FULL YEAR 2024 REVENUE OF APPROXIMATELY $174
MILLION
Source text: ID:nGNXF0yqy
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07